BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16809323)

  • 1. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype.
    Grossmann C; Podgrabinska S; Skobe M; Ganem D
    J Virol; 2006 Jul; 80(14):7179-85. PubMed ID: 16809323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.
    Sakakibara S; Pise-Masison CA; Brady JN; Tosato G
    J Virol; 2009 Mar; 83(5):2140-53. PubMed ID: 19091861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
    Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
    Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
    An J; Sun Y; Sun R; Rettig MB
    Oncogene; 2003 May; 22(22):3371-85. PubMed ID: 12776188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Xu Y; Ganem D
    J Gen Virol; 2007 Jan; 88(Pt 1):46-50. PubMed ID: 17170435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
    J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.
    Alkharsah KR; Singh VV; Bosco R; Santag S; Grundhoff A; Konrad A; Stürzl M; Wirth D; Dittrich-Breiholz O; Kracht M; Schulz TF
    J Virol; 2011 Oct; 85(19):10375-88. PubMed ID: 21795355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.
    Thurau M; Marquardt G; Gonin-Laurent N; Weinländer K; Naschberger E; Jochmann R; Alkharsah KR; Schulz TF; Thome M; Neipel F; Stürzl M
    J Virol; 2009 Jan; 83(2):598-611. PubMed ID: 18987137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis.
    Pati S; Cavrois M; Guo HG; Foulke JS; Kim J; Feldman RA; Reitz M
    J Virol; 2001 Sep; 75(18):8660-73. PubMed ID: 11507211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
    Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
    PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
    Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
    J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spindle cells and their role in Kaposi's sarcoma.
    Gessain A; Duprez R
    Int J Biochem Cell Biol; 2005 Dec; 37(12):2457-65. PubMed ID: 16188485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
    Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
    PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.
    Ding X; Xu J; Wang C; Feng Q; Wang Q; Yang Y; Lu H; Wang F; Zhu K; Li W; Yan Q; Gao SJ; Lu C
    Cell Death Differ; 2019 Oct; 26(10):1970-1986. PubMed ID: 30670829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells.
    Haas DA; Bala K; Büsche G; Weidner-Glunde M; Santag S; Kati S; Gramolelli S; Damas M; Dittrich-Breiholz O; Kracht M; Rückert J; Varga Z; Keri G; Schulz TF
    PLoS Pathog; 2013; 9(11):e1003737. PubMed ID: 24244164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. vFLIP from KSHV inhibits anoikis of primary endothelial cells.
    Efklidou S; Bailey R; Field N; Noursadeghi M; Collins MK
    J Cell Sci; 2008 Feb; 121(Pt 4):450-7. PubMed ID: 18211958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
    DiMaio TA; Gutierrez KD; Lagunoff M
    PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.